Page last updated: 2024-10-29

iohexol and Peritoneal Neoplasms

iohexol has been researched along with Peritoneal Neoplasms in 6 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.

Research Excerpts

ExcerptRelevanceReference
"To prospectively analyze the evolution of hepatic and peritoneal unresectable metastases from gastrointestinal stromal tumors (GIST) under imatinib mesylate, a new targeted treatment, which induces changes in lesion structure."3.73Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients. ( Albiter, M; Bonvalot, S; Caillet, H; Dromain, C; Le Cesne, A; Le Pechoux, C; Petrow, P; Shapeero, L; Terrier, P; Vanel, D, 2005)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gadelhak, B1
Tawfik, AM1
Saleh, GA1
Batouty, NM1
Sobh, DM1
Hamdy, O1
Refky, B1
Koo, PJ1
Wills, JS1
Lakhman, Y1
Akin, O1
Sohn, MJ1
Zheng, J1
Moskowitz, CS1
Iyer, RB1
Barakat, RR1
Sabbatini, PJ1
Chi, DS1
Hricak, H1
Vanel, D1
Albiter, M1
Shapeero, L1
Le Cesne, A1
Bonvalot, S1
Le Pechoux, C1
Terrier, P1
Petrow, P1
Caillet, H1
Dromain, C1
Yenarkarn, P1
Thoeni, RF1
Hanks, D1
Low, RN1
Semelka, RC1
Worawattanakul, S1
Alzate, GD1
Sigeti, JS1

Other Studies

6 other studies available for iohexol and Peritoneal Neoplasms

ArticleYear
Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index (PCI) prior to cytoreductive surgery.
    Abdominal radiology (New York), 2019, Volume: 44, Issue:6

    Topics: Adnexal Diseases; Contrast Media; Cytoreduction Surgical Procedures; Female; Humans; Iohexol; Magnet

2019
Case 146: Benign multicystic mesothelioma.
    Radiology, 2009, Volume: 251, Issue:3

    Topics: Adult; Contrast Media; Diagnosis, Differential; Female; Humans; Iohexol; Mesothelioma, Cystic; Perit

2009
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.
    AJR. American journal of roentgenology, 2012, Volume: 198, Issue:6

    Topics: Contrast Media; Diatrizoate; Disease Progression; Fallopian Tube Diseases; Female; Humans; Iohexol;

2012
Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.
    European journal of radiology, 2005, Volume: 54, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Contrast Media; Female; Follow-Up Studies; Gastroint

2005
Case 107: lymphoma of the mesentery.
    Radiology, 2007, Volume: 242, Issue:2

    Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Diatrizoate Meglumine; Hepatitis

2007
Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT, with subsequent surgical correlation.
    Radiology, 1999, Volume: 210, Issue:3

    Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate; False Negative Rea

1999